Author:
Lin Hao,Wu Chen-Hsuan,Fu Hung-Chun,Ou Yu-Che
Reference57 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Differences in tumor behavior between serous and non-serous ovarian carcinoma, focus on distribution of stage, laterality and survival;Liu;Eur J Gynaecol Oncol,2019
3. ICON7 trial investigators. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial;Oza;Lancet Oncol,2015
4. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N Engl J Med,2011
5. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial;Banerjee;Lancet Oncol,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献